124 related articles for article (PubMed ID: 1419814)
21. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
22. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
Cascavilla N; Melillo L; D'Arena G; Greco MM; Carella AM; Sajeva MR; Perla G; Matera R; Minervini MM; Carotenuto M
Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
[TBL] [Abstract][Full Text] [Related]
23. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
24. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
25. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
[TBL] [Abstract][Full Text] [Related]
26. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
28. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Bosly A; Doyen C; Carli MG; Piva N; Castoldi G
Leuk Lymphoma; 1993 Mar; 9(4-5):285-91. PubMed ID: 8348065
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature.
Adriaansen HJ; Soeting PW; Wolvers-Tettero IL; van Dongen JJ
Leukemia; 1991 Sep; 5(9):744-51. PubMed ID: 1943227
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients.
Casasnovas RO; Campos L; Mugneret F; Charrin C; Béné MC; Garand R; Favre M; Sartiaux C; Chaumarel I; Bernier M; Faure G; Solary E
Leukemia; 1998 Jan; 12(1):34-43. PubMed ID: 9436918
[TBL] [Abstract][Full Text] [Related]
31. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
Lo Coco F; Lopez M; Pasqualetti D; Montefusco E; Cafolla A; Monarca B; Sgadari C; De Rossi G
Hematol Oncol; 1989; 7(2):167-74. PubMed ID: 2646199
[TBL] [Abstract][Full Text] [Related]
32. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
33. Surface marker analysis and karyotype distinguish acute biphenotypic leukemia from acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase.
Moscinski LC; Nowell PC; Hoxie JA; Berger MS; Prystowsky MB
Cancer; 1991 Nov; 68(10):2161-8. PubMed ID: 1913454
[TBL] [Abstract][Full Text] [Related]
34. High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase.
Seremetis SV; Pelicci PG; Tabilio A; Ubriaco A; Grignani F; Cuttner J; Winchester RJ; Knowles DM; Dalla-Favera R
J Exp Med; 1987 Jun; 165(6):1703-12. PubMed ID: 3473183
[TBL] [Abstract][Full Text] [Related]
35. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
36. Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.
Norton JD; Campana D; Hoffbrand AV; Janossy G; Coustan-Smith E; Jani H; Yaxley JC; Prentice HG
Leukemia; 1987 Nov; 1(11):757-61. PubMed ID: 3500372
[TBL] [Abstract][Full Text] [Related]
37. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
38. Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia.
Williams L; Moscinski LC
Leukemia; 1993 Sep; 7(9):1423-31. PubMed ID: 8371592
[TBL] [Abstract][Full Text] [Related]
39. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
40. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
Umiel T; Pattengale P; Weinberg K
Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
